Top

Published in:

01-11-2013 | Poster presentation

PB.33: Vacuum-assisted biopsy for lesions of uncertain malignant potential: further evidence of its suitability as a safe alternative to surgery

Authors: D Tzias, B Bhaludin, LS Wilkinson, S George, H Gay

Published in: Breast Cancer Research | Special Issue 1/2013

Excerpt

Increasing evidence supports vacuum-assisted biopsy (VAB) instead of surgical excision for the management of lesions of uncertain malignant potential (B3). This followed reports of up to 34% upgrade to malignancy on excision. In January 2012, regional guidance was adopted to clarify the options for managing such lesions. In our department, we have used similar local guidelines since 2011. We report our analysis of the management of B3 lesions before and after the introduction of VAB. …

Rajan S, Shaaban AM, Dall BJ, Sharma N: New patient pathway using vacuum-assisted biopsy reduces diagnostic surgery for B3 lesions. Clin Radiol. 2012, 67 (3): 244-9. 10.1016/j.crad.2011.09.002.CrossRefPubMed

Tennant SL, Evans A, Hamilton LJ, James J, Lee AH, Hodi Z, Ellis IO, Rakha EA, Wilson AR: Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected cases. Breast. 2008, 17 (6): 546-9. 10.1016/j.breast.2008.08.005.CrossRefPubMed

Lieske B, Ravichandran D, Alvi A, Lawrence DA, Wright DJ: Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised. Eur J Surg Oncol. 2008, 34 (12): 1293-8. 10.1016/j.ejso.2007.11.005.CrossRefPubMed

Wilkinson LS, Wells C, Teh W, Desai A, Wilson R: The management of indeterminate breast lesions - a clinicians guide. London region quality assurance reference centre. Guidance on management of indeterminate breast lesions. 2012

Title: PB.33: Vacuum-assisted biopsy for lesions of uncertain malignant potential: further evidence of its suitability as a safe alternative to surgery
Authors: D Tzias
B Bhaludin
LS Wilkinson
S George
H Gay
Publication date: 01-11-2013
Publisher: BioMed Central
Published in: Breast Cancer Research / Issue Special Issue 1/2013
Electronic ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr3533

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2013

PB.16: Contrast-enhanced digital mammography: a single-centre experience

PB.35: Comparison of large-bore vacuum-assisted biopsy and surgical diagnostic excision biopsy in B3 breast lesions

PB.07: Why are some fibroadenomas stiff using shear wave elastography?

PB.44: Audit of interval cancers from family history breast screening

PB.23: Effect of detector type on cancer detection in digital mammography

PB.03: Evaluating the role of breast MRI at mid-cycle chemotherapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer